eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2020
vol. 37
 
Share:
Share:
more
 
 
abstract:
Original paper

Clinical profile of chronic bronchial asthma patients in Poland: results of the PROKSAL study

Hanna Banasiak
1
,
Rafał Pawliczak
1

1.
Department of Immunopathology, Division of Allergology, Immunology and Dermatology, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
Adv Dermatol Allergol 2020; XXXVII (6): 879–889
Online publish date: 2021/01/06
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Asthma is a complex condition characterized by the presence of chronic inflammation in the lower respiratory tract resulting in many disturbing symptoms. The study of the clinical profile of the population with asthma allows us to understand a trend of a specific disease taking into account several indicators and its clinical characteristics.

Aim
Evaluation of the clinical profile of patients with chronic bronchial asthma in Poland.

Material and methods
The study included 10400 adult patients, of both sexes, diagnosed with chronic bronchial asthma who started therapy based on inhaled glucocorticosteroids accompanied by salmeterol, and 52 allergists. The examination was performed in a doctor’s surgery. Standardized questionnaire interviews were used in order to carry out the procedure.

Results
The age of the patients ranged from 18 up to 97 years. Most of them suffer from overweight and obesity. 45.3% of the patients smoked cigarettes or declared to be passive smokers. Current asthma control was poor: over 56% of the patients suffered from diurnal symptoms more often than twice a week, almost 55% from nocturnal symptoms, in 72% of the patients’ physical activity was limited, whereas 57% required immediate treatment. Most commonly used drugs were inhaled glucocorticosteroids and short acting b2-mimetics. After treatment change, fewer patients suffered from asthma symptoms.

Conclusions
Adjusting the therapy according to the current guidelines and to the patient’s needs helps to improve asthma control.

keywords:

asthma, clinical profile, PROKSAL, allergy, inhaled glucocorticosteroids

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe